Haruchika Masuda

Prof. Dr. Haruchika Masuda

Department of Physiology, Tokai University School of Medicine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2014 in Journal of the American Heart Association
Verified
Journal Article
Open access
HMHaruchika Masuda
Haruchika Masuda
RTRica Tanaka
Rica Tanaka
SFSatoshi Fujimura
Satoshi Fujimura
MIMasakazu Ishikawa
Masakazu Ishikawa
HAHiroshi Akimaru
Hiroshi Akimaru
TATakayuki Asahara
Takayuki Asahara
Background: Cell‐based therapies involving mononuclear cells ( MNC s) have been developed for vascular regeneration to treat ischemic diseases; however, quality control of therapeutic MNC s has not been evaluated. We investigated the therapeutic potential of peripheral blood ( PB ) MNC s, operated by recently developed quality and quantity ( QQ ) culture of endothelial progenitor cells ( EPC s). Methods and Results: PBs were collected from healthy volunteers; peripheral blood mononuclear cells ( PBMNC s) isolated from these PB s were subjected to QQ culture for 7 days with medium containing stem cell factor, thrombopoietin, Flt‐3 ligand, vascular endothelial growth factor, and interleukin‐6. The resulting cells ( QQMNC s) in EPC colony‐forming assay generated significantly more definitive EPC colonies than PBMNC s. In flow cytometry, macrophages and helper T lymphocytes of QQMNC s became phenotypically polarized into angiogenic, anti‐inflammatory, and regenerative subsets: classical M1 to alternative M2; T helper (Th)1 to Th2; angiogenic or regulatory T‐cell expansion. Quantitative real‐time polymerase chain reaction ( qRT ‐ PCR ) assay revealed the predominant proangiogenic gene expressions in QQMNC s versus PBMNC s. Using murine ischemic hindlimb models, the efficacy of QQMNC intramuscular transplantation (Tx) was compared to that of PBMNCTx , cultured “early EPC ” Tx ( eEPCTx ), and granulocyte colony‐stimulating factor mobilized CD34 + cell Tx (GmCD34Tx). Laser Doppler imaging revealed the blood perfusion recovery in ischemic hindlimbs after QQMNCTx superior to after PBMNCTx and eEPCT x, but also earlier than after GmCD34Tx. Histological evaluations and q RT ‐ PCR assays in ischemic hindlimbs demonstrated that QQMNCTx , similarly to GmCD34Tx, enhanced angiovasculogenesis and myogenesis, whereas it preponderantly inhibited inflammation and fibrosis versus PBMNCTx and eEPCTx . Conclusions: QQ culture potentiates the ability of PBMNC s to promote regeneration of injured tissue; considering the feasible cell preparation, QQ culture‐treated PBMNC s may provide a promising therapeutic option for ischemic diseases. Clinical Trial Registration: URL : irb.med.u-tokai.ac.jp/d/2/monthly/2010.html ; IRB No.: 10R‐020. URL : irb.med.u-tokai.ac.jp/d/2/monthly/201312.html ; IRB No.: 13R228.

28 February 2013 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
STShizu Tsukada
Shizu Tsukada
SKSang Mo Kwon
Sang Mo Kwon
TMTakenori Matsuda
Takenori Matsuda
SJSeok-Yun Jung
Seok-Yun Jung
JLJun Hee Lee
Jun Hee Lee
TATakayuki Asahara
Takayuki Asahara
Introduction: Endothelial progenitor cells (EPCs) play a critical role in restoration of ischemic diseases. However, the actual status of EPC development and the mechanisms of EPC dysfunctions in patients with various ischemic diseases remain unknown. Methods: To investigate the detailed function of EPCs in experimental murine models, we have established an EPC colony forming assay (EPC-CFA) in murine EPCs. The abilities of murine EPCs in differentiation, adhesive capacity, proliferative potency, and transplantation in vitro and in vivo were then examined. Results: Peripheral blood mononuclear cells (PB-MNCs), bone marrow mononuclear cells (BM-MNCs) or bone marrow c-Kit+/Sca-1+ lineage negative (BM-KSL) cells differentiated into two types of EPC colony forming units (EPC-CFUs), large sized EPC (large-EPC)-CFUs and small sized EPC (small-EPC)-CFUs. Gene expression analysis demonstrated that both EPC-CFU-derived cells expressed eNOS, Flk-1 and VE-cadherin, markers of endothelial cells (ECs), although the small-EPCs derived from small-EPC-CFU were higher in number and showed more immature features (higher population of KSL cells). Functionally, the large-EPCs derived from large-EPC-CFU had higher adhesive capacity but lower proliferative potency than small-EPCs, showing improved tubular forming capacity and incorporation potency into primary EC-derived tube formation. Importantly, hindlimb ischemia increased the frequencies of large-EPC-CFUs differentiated from PB-MNCs and bone marrow. Actually, transplantation of large-EPCs into ischemic hindlimb enhanced neovascularization in hindlimb ischemia model, although small-EPCs or murine ECs did not, suggesting that large-EPC-CFUs might play an important role in restoration of ischemic diseases. Conclusions: We demonstrated, using a murine ischemia model, that the EPC-CFA could be a useful way to investigate the differentiation levels of murine EPCs, further providing a crucial clue that large-EPC-CFU status may be more functional or effective EPCs to promote neovascularization.

16 August 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HMHaruchika Masuda
Haruchika Masuda
ASAtsuko Sato
Atsuko Sato
TSTomoko Shizuno
Tomoko Shizuno
KYKeiko Yokoyama
Keiko Yokoyama
YSYusuke Suzuki
Yusuke Suzuki
TATakayuki Asahara
Takayuki Asahara
Batroxobin, isolated from Bothrops moojeni, is a defibrinogenating agent used as a thrombin-like serine protease against fibrinogen for improving microcirculation. Here, we investigated whether, and if so, how batroxobin restores ischemic tissue injury in terms of anti-inflammatory effects. In an in vitro flow cytometry assay for human neutrophil extracellular traps (NETs), batroxobin (DF-521; Defibrase) inhibited human NETs induced by tumor necrosis factor-α (TNF-α) in the presence of human fibrinogen. Next, the effect of batroxobin was investigated by immunohistochemistry of the anterior tibial muscle (ATM) in an ischemic hindlimb model using C57BL/6J mice intraperitoneally injected with DF-521 versus the saline control. NETs and fibrinogen deposition in the ischemic ATM decreased in DF-521-treated mice on day 2 after ischemia. Meanwhile, reverse transcription-quantitative PCR assay of the ischemic ATM unveiled continuous downregulation in the expression of the genes; Tnf-α and nitric oxide synthase2 (Nos2) with hypoxia-inducible factor-1α (Hif-1α) and vascular endothelial growth factor-a (Vegf-a) from day 3 to day 7, but the upregulation of arginase-1 (Arg-1) and placental growth factor (Plgf) with myogenin (Myog) on day 7. Daily intraperitoneal DF-521 injection for the initial 7 days into mice with ischemic hindlimbs promoted angiogenesis and arteriogenesis on day 14. Moreover, DF-521 injection accelerated myofiber maturation after day 14. Laser doppler imaging analysis revealed that blood perfusion in DF-521-injected mice significantly improved on day 14 versus the saline control. Thus, DF-521 improves microcirculation by protecting NETs with tissue defibrinogenation, thereby protecting against severe ischemic tissue injury and accelerating vascular and skeletal muscular regeneration. To our knowledge, batroxobin might be the first clinically applicable NET inhibitor against ischemic diseases.

14 November 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Eiichiro NagataEiichiro Nagata
Eiichiro Nagata
HMHaruchika Masuda
Haruchika Masuda
TNTaira Nakayama
Taira Nakayama
SNShizuka Netsu
Shizuka Netsu
HYHiroko Yuzawa
Hiroko Yuzawa
STShunya Takizawa
Shunya Takizawa
Moyamoya disease (MMD) is well known to be caused by insufficient cerebral vascular formation. However, the essential pathogenesis has not yet been identified. Using our recently developed technique of generating vasculogenic and anti-inflammatory cultures, we investigated endothelial progenitor cell (EPC) expansion and differentiation under the cytokine milieu generated by the peripheral blood mononuclear cells (PBMNCs) of the operated and non-operated MMD patients. EPC colony forming assay of the cultured PBMNCs disclosed the decline of the definitive EPC colony numbers in the both MMD patients. The level of interleukin-10 (IL-10) was lower in secretory cytokines from the cultured PBMNCs of MMD patients than that in that of controls using a cytometric bead array. The addition of human recombinant IL-10 to PBMNCs cultured from MMD patients restored the EPC colony forming potential of MMD PBMNCs. Following phorbol myristate acetate stimulation of the cultured PBMNCs, flow cytometry revealed a decrease in intracellular IL-10 storage in the main cell populations of the PBMNCs cultured from MMD patients relative to those cultured from controls. The present data provide the expected mechanism of vascular malformation in MMD pathogenesis originated from the insufficient production of IL-10 secreting cells from PBMNCs fostering EPC expansion and differentiation.

8 June 2019 in Sensors
Verified
Journal Article
Open access
PDF file
SYShin Yagiahara
Shin Yagiahara
RKRio Kita
Rio Kita
NSNaoki Shinyashiki
Naoki Shinyashiki
HSHironobu Saito
Hironobu Saito
YMYuko Maruyama
Yuko Maruyama
Masayuki TokitaMasayuki Tokita
Masayuki Tokita
The dynamics of a hydrogen bonding network (HBN) relating to macroscopic properties of hydrogen bonding liquids were observed as a significant relaxation process by dielectric spectroscopy measurements. In the cases of water and water rich mixtures including biological systems, a GHz frequency relaxation process appearing at around 20 GHz with the relaxation time of 8.2 ps is generally observed at 25 °C. The GHz frequency process can be explained as a rate process of exchanges in hydrogen bond (HB) and the rate becomes higher with increasing HB density. In the present work, this study analyzed the GHz frequency process observed by suitable open-ended coaxial electrodes, and physical meanings of the fractal nature of water structures were clarified in various aqueous systems. Dynamic behaviors of HBN were characterized by a combination of the average relaxation time and the distribution of the relaxation time. This fractal analysis offered an available approach to both solution and dispersion systems with characterization of the aggregation or dispersion state of water molecules. In the case of polymer-water mixtures, the HBN and polymer networks penetrate each other, however, the HBN were segmented and isolated more by dispersed and aggregated particles in the case of dispersion systems. These HBN fragments were characterized by smaller values of the fractal dimension obtained from the fractal analysis. Some examples of actual usages suggest that the fractal analysis is now one of the most effective tools to understand the molecular mechanism of HBN in aqueous complex materials including biological systems.

20 August 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAmankeldi A. Salybekov
Amankeldi A. Salybekov
AKAkira T Kawaguchi
Akira T Kawaguchi
HMHaruchika Masuda
Haruchika Masuda
KVKosit Vorateera
Kosit Vorateera
COChisa Okada
Chisa Okada
TATakayuki Asahara
Takayuki Asahara
Background: Considering the impaired function of regenerative cells in patients with comorbidities and associated risk factors, cell therapy to enhance the regenerative microenvironment was designed using regeneration-associated cells (RACs), including endothelial progenitor cells (EPCs) and anti-inflammatory cells. Methods: RACs were prepared by quality and quantity control culture of blood mononuclear cells (QQMNCs). The peripheral blood mononuclear cells (PBMNCs) were isolated from Lewis rats and conditioned for 5 days using a medium containing stem cell factors, thrombopoietin, Flt-3 ligand, vascular endothelial growth factor, and interleukin-6 to generate QQMNCs. Results: In vitro EPC colony forming assays demonstrated a 5.3-fold increase in the definitive colony-forming EPCs and vasculogenic EPCs, in comparison to naïve PBMNCs. Flow cytometry analysis revealed that QQMNCs were enriched with RACs, such as EPCs (28.9-fold, P<0.0019) and M2 macrophages (160.3-fold, P<0.0002). Cell transcriptome analysis revealed that angiogenesis ( angpt1, angpt2, and vegfb ), stem/progenitor ( c-kit and sca-1 ) and anti-inflammation related ( arg-1, erg-2, tgfb, and foxp3 ) genes were highly expressed in QQMNCs. For in vivo cell transplantation experiments, 1×10 5 cells were administered via the tail vein into syngeneic rat models of myocardial infarction (MI). Echocardiographic data showed that QQMNCs-transplanted group (QQ-Tx) preserved cardiac function and fraction shortening (45.5±4.6%) at 28-days post-MI in comparison with PBMNCs-transplanted (PB-Tx) (30.9±6.4%, P<0.0001) and Control (32.2±7.7%, P<0.0008) groups. Histological analysis revealed that QQ-Tx showed enhanced angiogenesis and reduced interstitial left ventricular fibrosis, along with a decrease in neutrophils and an increase in M2 macrophages in the acute phase of MI. Cell tracing studies revealed that intravenously administered QQMNCs preferentially homed to ischemic tissues via blood circulation, while PBMNCs did not. QQ-Tx showed markedly upregulated early cardiac transcriptional cofactors ( Nkx2-5, 29.8-fold, and Gata-4 , 5.2- fold) as well as c-kit (4.5-fold) while these markers were downregulated in PB-Tx. In QQ-Tx animals, de novo blood vessels formed a “Biological Bypass” as observed macroscopically and microscopically, while PB-Tx and Control-Tx groups never developed epicardial blood vessels but showed severe fibrotic adhesion to the surrounding tissues. Conclusion: QQMNCs, as RACs derived from rat PBMNCs, conferred potent angiogenic and anti-inflammatory properties to the regenerative microenvironment, enhancing myocardiogenesis and functional recovery of rat MI hearts.